SCHEMBL20339856

SCHEMBL20339856

Cc1ccc2cc(-c3cnnc(C)c3)n(C3CC3)c2c1

nearest known ligand 0.78

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CYP11B2 P19099 19/20 0.78
▸ CYP11B1 P15538 14/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20338177 0.88 CYP11B2 (1.00) CYP11B2CYP11B1
SCHEMBL20340104 0.85 CYP11B2 (0.71) CYP11B2CYP11B1
SCHEMBL20340188 0.84 CYP11B2 (0.73) CYP11B2CYP11B1
SCHEMBL20340235 0.82 CYP11B2 (0.74) CYP11B2CYP11B1
SCHEMBL20340211 0.80 CYP11B2 (0.67) CYP11B2CYP11B1
SCHEMBL20338349 0.80 CYP11B2 (1.00) CYP11B2CYP11B1
SCHEMBL20340212 0.78 CYP11B2 (0.67) CYP11B2CYP11B1
SCHEMBL20340219 0.77 CYP11B2 (0.69) CYP11B2CYP11B1
SCHEMBL20340160 0.77 CYP11B2 (0.65) CYP11B2CYP11B1
SCHEMBL20340019 0.74 CYP11B2 (0.68) CYP11B2CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3562487-A2 METALLOENZYME INHIBITOR COMPOUNDS Selenity Therapeutics (Bermuda), Ltd. (BM) 2019-11-06 — — EP disclosed
WO-2018125800-A2 METALLOENZYME INHIBITOR COMPOUNDS VIAMET PHARMACEUTICALS (BERMUDA), LTD. (BM) 2018-07-05 — — WO disclosed
Send feedback